NeuroMetrix, Inc. (NURO)

NeuroMetrix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.73	4.34	22.57	5.23	3.13
Short-Term Investments	16.27	16.86	0	0	0
Cash & Cash Equivalents	18	21.2	22.57	5.23	3.13
Cash Growth	-15.11%	-6.08%	331.90%	67.17%	-53.89%
Receivables	0.52	0.65	0.31	0.33	0.49
Inventory	1.56	1.61	0.71	1.05	1.16
Other Current Assets	0.78	0.65	0.6	0.48	0.65
Total Current Assets	20.85	24.11	24.19	7.09	5.43
Property, Plant & Equipment	0.54	0.54	0.67	0.88	1.43
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.03
Total Long-Term Assets	0.57	0.56	0.7	0.9	1.46
Total Assets	21.42	24.67	24.89	7.99	6.89
Accounts Payable	0.22	0.37	0.28	0.14	0.73
Current Debt	0.15	0.15	0.23	0.6	0.59
Other Current Liabilities	0.88	0.59	0.85	1.54	2.13
Total Current Liabilities	1.24	1.11	1.37	2.29	3.45
Long-Term Debt	0.09	0.21	0.31	0.46	0.92
Total Long-Term Liabilities	0.09	0.21	0.31	0.46	0.92
Total Liabilities	1.33	1.31	1.67	2.75	4.36
Total Debt	0.24	0.36	0.54	1.06	1.51
Debt Growth	-32.32%	-33.50%	-49.56%	-29.51%	-19.88%
Retained Earnings	-210.11	-203.58	-199.16	-196.88	-194.79
Comprehensive Income	0.24	0	0	0	0
Shareholders' Equity	20.09	23.36	23.22	5.25	2.53
Net Cash / Debt	17.76	20.84	22.04	4.17	1.62
Net Cash / Debt Growth	-14.81%	-5.41%	429.08%	156.95%	-66.93%
Working Capital	19.61	23	22.82	4.8	1.98
Book Value Per Share	18.71	24.09	27.95	11.09	20.69

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).